American Journal of Psychiatry

In Search of Biomarkers to Guide Interventions in Autism Spectrum Disorder: A Systematic Review.  180:23-40. 2023

The Autism Biomarkers Consortium for Clinical Trials: Initial Evaluation of a Battery of Candidate EEG Biomarkers.  180:41-49. 2023

Risks and Benefits of Cannabis and Cannabinoids in Psychiatry.  179:98-109. 2022

Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma.  178:1037-1049. 2021

Neurocognitive Profiles Predict Susceptibility and Resilience to Posttraumatic Stress.  178:991-993. 2021

Evaluating the Machine Learning Literature: A Primer and User's Guide for Psychiatrists.  178:715-729. 2021

Neuroimaging Biomarkers in Schizophrenia.  178:509-521. 2021

Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study.  176:428-438. 2019

Role of complex epigenetic switching in tumor necrosis factor-α upregulation in the prefrontal cortex of suicide subjects.  175:262-274. 2018

Mixed depression in bipolar disorder: Prevalence rate and clinical correlates during naturalistic follow-up in the stanley bipolar network.  173:1015-1023. 2016

A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression.  173:816-826. 2016

Making progress toward individualized medicine in the treatment of psychosis.  173:5-7. 2016

Ziprasidone augmentation of escitalopram for major depressive disorder: Efficacy results from a randomized, Double-Blind, Placebo-Controlled Study.  172:1251-1258. 2015

Social and nonsocial cognition in bipolar disorder and schizophrenia: Relative levels of impairment.  170:334-341. 2013

L-methylfolate as adjunctive therapy for SSRI-resistant major depression: Results of two randomized, double-blind,,parallel-sequential trials.  169:1267-1274. 2012

Does concomitant use of NSAIDs reduce the effectiveness of antidepressants?.  169:1012-1015. 2012

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and long-term outcomes of a single-blind randomized study.  168:689-701. 2011

Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia.  168:286-292. 2011

Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Outcome Network.  167:708-715. 2010

Project Among African-Americans to Explore Risks for schizophrenia (paartners): Evidence for impairment and heritability of Neurocognitive functioning in families of schizophrenia patients.  167:459-472. 2010

Drs. Frye and Helleman reply.  166:830. 2009

Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.  166:164-172. 2009

Relation of lifetime trauma and depressive symptoms to mortality in HIV.  164:1707-1713. 2007

Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.  164:1206-1213. 2007

Negative signs and symptoms secondary to antipsychotics: A double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.  163:488-493. 2006

Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.  162:118-123. 2005

Schizophrenia, VIII.  160:2091. 2003

Microarray technology: A review of new strategies to discover candidate vulnerability genes in psychiatric disorders.  160:657-666. 2003

Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia.  159:1490-1496. 2002

Higher expression of serotonin 5-HT2A receptors in the postmortem brains of teenage suicide victims.  159:419-429. 2002

[³H]cAMP binding sites and protein kinase A activity in the prefrontal cortex of suicide victims.  159:66-73. 2002

Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task.  158:1797-1808. 2001

A novel augmentation strategy for treating resistant major depression.  158:131-134. 2001

Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task.  157:1634-1645. 2000

Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C β1 protein in the prefrontal cortex of teenage suicide subjects.  156:1895-1901. 1999

Association between eye tracking disorder in schizophrenia and poor sensory integration.  155:1352-1357. 1998

Clinical genetics, V: Association of genetic and personality characteristics.  154:1496. 1997

Direct assessment of functional status in older patients with schizophrenia.  154:1022-1024. 1997

Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: Psychosocial outcomes.  154:390-395. 1997

Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients.  153:1158-1165. 1996

cAMP-dependent protein kinase activity in major depression.  153:1037-1042. 1996

Platelet serotonin-2A receptors: A potential biological marker for suicidal behavior.  152:850-855. 1995

Anxiety disorders in a neuromuscular clinic.  150:1102-1104. 1993

Methadone dosage, cocaine and opiate abuse [5].  150:675. 1993

Psychiatric illnesses in families of subjects with schizophrenia-spectrum personality disorders: High morbidity risks for unspecified functional psychoses and schizophrenia.  150:66-71. 1993

Cigarette use and hyponatremia in schizophrenic patients [11].  148:688-689. 1991

Role of cigarette use in hyponatremia in schizophrenic patients.  147:1075-1077. 1990

Methods of measuring thyroid hormone levels..  145:266. 1988

Cerebral structural pathology in schizophrenia: Evidence for a selective prefrontal cortical defect.  145:154-163. 1988

Psychiatric decision making in the emergency room: a research overview.  145:918-925. 1988

A relationship between anatomical and physiological brain pathology in schizophrenia: Lateral cerebral ventricular size predicts cortical blood flow.  144:1277-1282. 1987

Case report of ECT during high-risk pregnancy.  141:99-101. 1984

Spinal fluid changes during chlorpromazine therapy.  115:167-168. 1958